MX9302986A - Medicamento que contiene metrifonato y procedimiento para su preparacion - Google Patents

Medicamento que contiene metrifonato y procedimiento para su preparacion

Info

Publication number
MX9302986A
MX9302986A MX9302986A MX9302986A MX9302986A MX 9302986 A MX9302986 A MX 9302986A MX 9302986 A MX9302986 A MX 9302986A MX 9302986 A MX9302986 A MX 9302986A MX 9302986 A MX9302986 A MX 9302986A
Authority
MX
Mexico
Prior art keywords
pct
metrifonate
procedure
preparation
medicines containing
Prior art date
Application number
MX9302986A
Other languages
English (en)
Inventor
Michael Boberg
Wolfgang Kanhai
Armin Kern
Volker Muschalek
Ulrich Pleiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX9302986A publication Critical patent/MX9302986A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se ha encontrado un medicamento que contienen metrifonato, el cual contienen al metrifonato enantiómero como única substancia activa. El (-)-metrifonato es básicamente mejor inhibidor de la colineresterasa, que el rasemato, con esto se puede disminuir la cantidad de substancia activa y consecuentemente por ejemplo el tamaño de las tabletas.
MX9302986A 1992-05-26 1993-05-21 Medicamento que contiene metrifonato y procedimiento para su preparacion MX9302986A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4217396A DE4217396A1 (de) 1992-05-26 1992-05-26 Metrifonat enthaltendes Arzneimittel

Publications (1)

Publication Number Publication Date
MX9302986A true MX9302986A (es) 1993-12-01

Family

ID=6459760

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302986A MX9302986A (es) 1992-05-26 1993-05-21 Medicamento que contiene metrifonato y procedimiento para su preparacion

Country Status (10)

Country Link
US (1) US5629300A (es)
EP (1) EP0669826B1 (es)
JP (1) JPH07507280A (es)
AT (1) ATE169819T1 (es)
CA (1) CA2136548A1 (es)
DE (2) DE4217396A1 (es)
DK (1) DK0669826T3 (es)
ES (1) ES2122005T3 (es)
MX (1) MX9302986A (es)
WO (1) WO1993024130A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807931D0 (en) * 1998-04-15 1998-06-10 Medical Res Council Improvements in or relating to protease inhibitors
DE19857716A1 (de) * 1998-12-15 2000-06-21 Bayer Ag Neue feste Formulierung von Metrifonat
WO2015017328A2 (en) 2013-07-29 2015-02-05 Spallitta Frank Anthony Organophosphates for treating afflictions of the skin
US11446241B2 (en) 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
LT3157534T (lt) 2014-06-19 2022-09-12 Attillaps Holdings Acetilcholinesterazės inhibitoriai, skirti dermatologinių būklių gydymui

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950658A (en) * 1988-12-06 1990-08-21 Board Of Trustees Of Southern Illinois Univ. Method of medical treatment of Alzheimer's disease

Also Published As

Publication number Publication date
DE4217396A1 (de) 1993-12-02
JPH07507280A (ja) 1995-08-10
ATE169819T1 (de) 1998-09-15
EP0669826A1 (de) 1995-09-06
WO1993024130A1 (de) 1993-12-09
DE59308900D1 (de) 1998-09-24
CA2136548A1 (en) 1993-12-09
US5629300A (en) 1997-05-13
ES2122005T3 (es) 1998-12-16
DK0669826T3 (da) 1999-05-25
EP0669826B1 (de) 1998-08-19

Similar Documents

Publication Publication Date Title
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
PT83872A (de) Arzneimittel
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
DE59509751D1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
FI954990A0 (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
ES8705762A1 (es) Procedimiento para preparar un agente analgesicamente activo a base de 2-amino-3-carboetoxiamino-6-(4-fluorobencilamino)-piridina y por lo menos un agente antiflogistico no esteroidal
BR9306412A (pt) Formulaç o pesticida tixotrópica e método para proteç o de plantaç es
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE59403965D1 (de) Synergistische lichtschutzkombinationen und kosmetische und dermatologische formulierungen, solche kombinationen enthaltend
ES2090712T3 (es) Medicamento agudo que contiene ibuprofeno y su uso.
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
CA2129527A1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r)
ATE215367T1 (de) Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung
ES2082523T3 (es) Un medicamento de accion retardada que contiene ibuprofen y su empleo.
AU7025087A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
ES2170377T3 (es) Composicion que contiene quitosana.
ES2085657T3 (es) Un medicamento de accion retardada que contiene flurbiprofeno y su utilizacion.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees